HXHX Haoxin Holdings Ltd
Price Chart
Executive Summary
Haoxin Holdings issued $1.2M aggregate principal amount of convertible promissory notes (net proceeds $1M) to Mermaid Money, along with a $30M equity line of credit and a commitment warrant. The notes carry a 7% interest rate, are convertible at a 10% discount to the lowest VWAP over the prior 5 days (with a floor price set at 20% of Nasdaq's minimum price on the subscription date), and include highly dilutive anti-dilution and variable pricing provisions. The equity line allows the company to sell up to $30M of new shares at the investor's discretion over one year. This financing structure is severely dilutive to existing shareholders and signals acute cash needs, given the company's $5M market cap.
Actionable Insight
This is a distressed financing with severe dilution risk. The convertible note's variable pricing and floor price at 20% of Nasdaq minimum price means conversion could happen at extremely low prices, crushing existing holders. The $30M ELOC (6x current market cap) gives the investor a powerful short-selling hedge. Expect heavy downward pressure on HXHX shares as the investor converts and sells. Monitor for any registration statement filing for the resale of conversion shares, which would accelerate the dilution.
Key Facts
- Issued two convertible notes with aggregate principal of $1.2M, purchased at $1M (16.7% OID).
- Notes bear 7% interest (15% default rate), mature December 2027.
- Conversion price is the greater of floor price (20% of Nasdaq minimum price on subscription date) and 90% of lowest 5-day VWAP.
- Alternate conversion price on default is 70% of lowest 1-day traded price.
- Company also entered a $30M equity line of credit with same investor, valid through June 2027.
- Commitment warrant issued to investor; commitment fee of $900,000 payable in shares at lowest 30-day price before F-1 effectiveness.
- Company must reserve 200% of shares issuable upon conversion of notes.
- Market cap is only ~$5M; the $1.2M note and $30M ELOC represent massive potential dilution.
- Cross-filing context: 20-F filed 35 days ago shows 7.2M Class A and 4.8M Class B shares outstanding as of Dec 31, 2025.
Financial Impact
Immediate $1M cash infusion at 16.7% OID; potential dilution of 100%+ of current float from notes alone, and up to 6x current market cap from the ELOC.
Risk Factors
- Massive dilution from convertible notes and equity line of credit.
- Variable conversion pricing encourages aggressive short selling by the investor.
- Company may be unable to meet Nasdaq continued listing standards if share price falls further.
- Cross-filing 20-F shows only 12M total shares outstanding; this financing could more than double the share count.
- Default triggers (including failure to maintain registration or trading) could force redemption at 120% of conversion value.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-065364 |
| Document: ea029367801ex10-1.htm | 0001213900-26-065364 |
| Document: ea029367801ex10-3.htm | 0001213900-26-065364 |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access